Biotech's First IPO of 2024 Soared. Good Times Could Be Ahead for the Stocks.
Investor interest in newly-issued biotech stocks has been moribund for years, but the sector’s first IPO of 2024, CG Oncology, suggests that investors might...
United States Josh Nathan Kazis Oppenheimer Leland Gershell Oppenheimer Gershell Leland Gershell Apogee Therapeutics
Source: marketwatch.com